2011
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
Hermiller JB, Nikolsky E, Lansky AJ, Applegate RJ, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone GW. Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention 2011, 7: 307-13. PMID: 21729832, DOI: 10.4244/eijv7i3a54.Peer-Reviewed Original ResearchConceptsPaclitaxel-eluting stentsPercutaneous coronary interventionSegment restenosisYounger patientsElderly patientsLower incidenceSegment late lumen lossSegment late lossSPIRIT III trialTarget vessel failureLate lumen lossDrug-eluting stentsYears of ageThree-year resultsLower ratesAge-specific mechanismsStent assignmentAngiographic outcomesCoronary interventionIII trialsInducible ischaemiaEE patientsPE patientsLumen lossNeointimal response
2003
Percutaneous coronary interventions in octogenarians with use of glycoprotein GP llb/llla inhibitors: Similar major adverse cardiac events but higher hemorrhagic stroke rate than younger patients
Iakovou I, Dangas G, Mehran R, Mintz G, Lansky A, Kreps E, Collins M, Moussa I, Glasser L, Stone G, Leon M, Moses J. Percutaneous coronary interventions in octogenarians with use of glycoprotein GP llb/llla inhibitors: Similar major adverse cardiac events but higher hemorrhagic stroke rate than younger patients. Journal Of The American College Of Cardiology 2003, 41: 78. DOI: 10.1016/s0735-1097(03)80953-1.Peer-Reviewed Original Research